HomeCCCC • NASDAQ
add
C4 Therapeutics Inc
Previous close
$3.65
Day range
$3.57 - $3.72
Year range
$3.25 - $11.88
Market cap
252.71M USD
Avg Volume
1.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 15.36M | 38.75% |
Operating expense | 11.77M | 11.73% |
Net income | -24.67M | 8.77% |
Net profit margin | -160.56 | 34.25% |
Earnings per share | -0.35 | 34.80% |
EBITDA | -27.80M | -1.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 255.64M | 18.04% |
Total assets | 376.06M | 12.93% |
Total liabilities | 133.40M | 14.03% |
Total equity | 242.66M | — |
Shares outstanding | 70.59M | — |
Price to book | 1.06 | — |
Return on assets | -18.65% | — |
Return on capital | -22.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.67M | 8.77% |
Cash from operations | -24.13M | 21.41% |
Cash from investing | 162.00K | -99.72% |
Cash from financing | 10.51M | 197.70% |
Net change in cash | -13.46M | -182.79% |
Free cash flow | -25.05M | -45.97% |
About
Founded
2015
Headquarters
Website
Employees
145
